Mukherji Ashutosh, Sinnatamby Mourougan
Department of Radiotherapy.
Department of Medical Physics, Regional Cancer Centre, JIPMER, Puducherry, India.
J Contemp Brachytherapy. 2017 Apr;9(2):167-173. doi: 10.5114/jcb.2017.67392. Epub 2017 Apr 26.
Soft tissue sarcomas of the extremities account for half of all soft tissue sarcomas. Radiotherapy and surgery have been the standard modalities in the treatment of this type of cancer. Brachytherapy can be used as the sole therapy, if the target volume is localized and easily accessible. This work reports three cases of shoulder soft tissue sarcomas with positive deep resected margins, treated with a combination of external beam radiotherapy and surface mould brachytherapy boost technique.
Between January and June 2014, three patients received brachytherapy with sites close to the shoulder, and post-surgery involved deep resected margins. Each mould was made on a base of thermoplastic, over which dental wax was coated and catheters implanted. The target volume was defined as the tissue covering the tumor bed with lateral margins of 2-2.5 cm and depth of 1-1.5 cm. Treatment planning was computed tomography-based and dose prescribed was 85-100% isodose. Treatments has been delivered twice daily, six hours interval, and a review of reactions evaluated.
Volume receiving more than 150% of the prescribed dose has been limited to less than 2%, and that above 200% to be inside the mould. Brachytherapy equivalent dose at 2 Gy per fraction (EQD) of these patients was 24 and 28.6 Gy. Maximum dose to organ at risk (OAR) (2 cc of OAR) ranged between 55-87% of prescribed dose, with a median dose being 80%. All cases had only grade 1 post-radiotherapy skin immediate reactions, which resolved within four weeks. In all patients, no treatment failures were noted at nearly 2-years post-irradiation.
Surface mould brachytherapy in soft tissue sarcomas could be a useful alternative to interstitial brachytherapy, especially where the target volume is superficially extensive with underlying critical structures, and where catheter placement may be difficult, such as the shoulder.
四肢软组织肉瘤占所有软组织肉瘤的一半。放疗和手术一直是这类癌症的标准治疗方式。如果靶区局限且易于到达,近距离放疗可作为单一治疗方法。本文报告了3例肩部软组织肉瘤患者,其手术切缘深部为阳性,采用外照射放疗联合表面模具近距离放疗增敏技术进行治疗。
2014年1月至6月期间,3例患者接受了肩部附近部位的近距离放疗,术后切缘深部阳性。每个模具以热塑性塑料为基底制作,其上涂覆牙科蜡并植入导管。靶区定义为覆盖肿瘤床的组织,外侧边缘为2 - 2.5厘米,深度为1 - 1.5厘米。治疗计划基于计算机断层扫描,处方剂量为85 - 100%等剂量线。治疗每天进行两次,间隔6小时,并评估反应情况。
接受超过处方剂量150%的体积限制在2%以下,超过200%的部分位于模具内。这些患者的近距离放疗等效剂量(每分次2 Gy,EQD)为24和28.6 Gy。危及器官(OAR)(2立方厘米的OAR)的最大剂量范围为处方剂量的55 - 87%,中位剂量为80%。所有病例放疗后皮肤即时反应均仅为1级,在4周内消退。所有患者在照射后近2年均未出现治疗失败情况。
对于软组织肉瘤,表面模具近距离放疗可能是组织间近距离放疗的一种有用替代方法,特别是在靶区表面广泛且下方有重要结构,以及导管放置可能困难的部位,如肩部。